Compare key investment metrics of 셀트리온 and 삼성바이오로직스 in real time. Both stocks belong to the 바이오 관련주 sector. View PER (Price-to-Earnings Ratio), PBR (Price-to-Book Ratio), dividend yield, market capitalization, and 52-week high/low side by side, with automatic highlighting of the leading stock for each metric.
Comparison at a Glance
- On earnings-based valuation, 셀트리온 trades at a lower PER — 33.66x vs 삼성바이오로직스's 45.65x. A lower PER can suggest undervaluation, but differences in growth expectations should also be considered.
- By market capitalization, 셀트리온 is larger — ₩40.9T vs 삼성바이오로직스's ₩6.5T. Larger companies tend to be less volatile, while smaller ones may offer more growth headroom.
- 셀트리온's current price of 175,900원 sits at about 22% of its 52-week range (158,500원–239,244원).
- 삼성바이오로직스's current price of 1,405,000원 sits at about 23% of its 52-week range (1,228,000원–1,987,000원).
- This comparison is for reference only, based on publicly available market data, and does not constitute investment advice.
| Metric | 셀트리온 | 삼성바이오로직스 |
|---|---|---|
| Price | 175,900원 | 1,405,000원 |
| PER | 33.66배 | 45.65배 |
| PBR | 2.29배 | 8.2배 |
| Dividend Yield | 0.41% | - |
| Market Cap | ₩40.9T | ₩6.5T |
| 52-Week High | 239,244원 | 1,987,000원 |
| 52-Week Low | 158,500원 | 1,228,000원 |
As of 2026-07-06 · Source: KRX (Naver Finance) public data
Frequently Asked Questions
Which has a lower PER, 셀트리온 or 삼성바이오로직스?
As of 2026-07-06, 셀트리온 has the lower PER — about 33.66x vs 삼성바이오로직스's 45.65x. PER (Price-to-Earnings Ratio) divides a stock's price by its earnings per share; a lower PER may suggest undervaluation, but growth expectations should also be considered.
What is the dividend yield difference between 셀트리온 and 삼성바이오로직스?
Dividend yield measures annual dividends as a percentage of the stock price. A higher yield means more cash income per dollar invested. The dividend yields of 셀트리온 and 삼성바이오로직스 fluctuate with dividend policy changes and stock price movements — check this page's live data for the most current comparison.
How to compare 셀트리온 and 삼성바이오로직스?
PFlow's stock comparison page lets you compare key investment metrics side by side — PER, PBR, dividend yield, market cap, and 52-week high/low. Each metric automatically highlights which stock has the advantage. For deeper analysis, visit each stock's dedicated detail page.